Published in Mol Microbiol on November 01, 1998
Process of protein transport by the type III secretion system. Microbiol Mol Biol Rev (2004) 3.31
Predictive and interpretive simulation of green fluorescent protein expression in reporter bacteria. J Bacteriol (2001) 1.64
A bacterial sensor of plant cell contact controls the transcriptional induction of Ralstonia solanacearum pathogenicity genes. EMBO J (2000) 1.44
Direct biochemical evidence for type III secretion-dependent translocation of the AvrBs2 effector protein into plant cells. Proc Natl Acad Sci U S A (2002) 1.33
Biological sensor for sucrose availability: relative sensitivities of various reporter genes. Appl Environ Microbiol (2001) 1.18
Yersinia enterocolitica targets cells of the innate and adaptive immune system by injection of Yops in a mouse infection model. PLoS Pathog (2009) 1.16
A degenerate type III secretion system from septicemic Escherichia coli contributes to pathogenesis. J Bacteriol (2005) 1.04
Expression analysis of the yersiniabactin receptor gene fyuA and the heme receptor hemR of Yersinia enterocolitica in vitro and in vivo using the reporter genes for green fluorescent protein and luciferase. Infect Immun (2001) 1.04
Arginine-143 of Yersinia enterocolitica YopP crucially determines isotype-related NF-kappaB suppression and apoptosis induction in macrophages. Infect Immun (2001) 1.00
An amino-terminal secretion signal is required for YplA export by the Ysa, Ysc, and flagellar type III secretion systems of Yersinia enterocolitica biovar 1B. J Bacteriol (2005) 1.00
Measurement of bacterial gene expression in vivo. Philos Trans R Soc Lond B Biol Sci (2000) 0.98
Attenuated Yersinia pseudotuberculosis carrier vaccine for simultaneous antigen-specific CD4 and CD8 T-cell induction. Infect Immun (2003) 0.98
A solvent-exposed patch in chaperone-bound YopE is required for translocation by the type III secretion system. J Bacteriol (2010) 0.93
The Yersinia YopE and YopH type III effector proteins enhance bacterial proliferation following contact with eukaryotic cells. BMC Microbiol (2001) 0.92
Oral vaccination with recombinant Yersinia enterocolitica expressing hybrid type III proteins protects gerbils from amebic liver abscess. Infect Immun (2004) 0.88
Yersinia enterocolitica type III secretion: evidence for the ability to transport proteins that are folded prior to secretion. BMC Microbiol (2004) 0.85
Unusual, virulence plasmid-dependent growth behavior of Yersinia enterocolitica in three-dimensional collagen gels. J Bacteriol (2008) 0.82
Growth control of small-colony variants by genetic regulation of the hemin uptake system. Infect Immun (2004) 0.82
Altered Ca(2+) regulation of Yop secretion in Yersinia enterocolitica after DNA adenine methyltransferase overproduction is mediated by Clp-dependent degradation of LcrG. J Bacteriol (2006) 0.79
Yersinia enterocolitica YopT and Clostridium difficile toxin B induce expression of GILZ in epithelial cells. PLoS One (2012) 0.79
Rapid methods for testing the efficacy of sterilization-grade filter membranes. Appl Environ Microbiol (2000) 0.77
LcrG secretion is not required for blocking of Yops secretion in Yersinia pestis. BMC Microbiol (2008) 0.77
Immunosuppressive Yersinia Effector YopM Binds DEAD Box Helicase DDX3 to Control Ribosomal S6 Kinase in the Nucleus of Host Cells. PLoS Pathog (2016) 0.76
A bacterial type III secretion-based protein delivery tool for broad applications in cell biology. J Cell Biol (2015) 0.75
Genetically manipulated virulence of Yersinia enterocolitica. Infect Immun (1984) 3.81
A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells. Infect Immun (1987) 3.76
Frequent loss of Shiga-like toxin genes in clinical isolates of Escherichia coli upon subcultivation. Infect Immun (1992) 3.47
Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins. EMBO J (2000) 3.23
Prevalence of the "high-pathogenicity island" of Yersinia species among Escherichia coli strains that are pathogenic to humans. Infect Immun (1998) 3.17
Double immunofluorescence microscopic technique for accurate differentiation of extracellularly and intracellularly located bacteria in cell culture. J Clin Microbiol (1985) 2.72
A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science (2001) 2.70
Development of PCR for screening of enteroaggregative Escherichia coli. J Clin Microbiol (1995) 2.66
Shiga-like toxin II-related cytotoxins in Citrobacter freundii strains from humans and beef samples. Infect Immun (1993) 2.47
Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect Immun (1994) 2.45
Clonal structure and pathogenicity of Shiga-like toxin-producing, sorbitol-fermenting Escherichia coli O157:H-. J Clin Microbiol (1993) 2.43
Immunochemical analysis of plasmid-encoded proteins released by enteropathogenic Yersinia sp. grown in calcium-deficient media. Infect Immun (1986) 2.42
Binding to collagen by Yersinia enterocolitica and Yersinia pseudotuberculosis: evidence for yopA-mediated and chromosomally encoded mechanisms. J Bacteriol (1989) 2.36
Construction of a mobilizable Yersinia enterocolitica virulence plasmid. J Bacteriol (1983) 2.33
Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect Immun (1994) 2.26
Plasmids of human strains of Yersinia enterocolitica: molecular relatedness and possible importance for pathogenesis. J Infect Dis (1983) 2.20
The yersiniabactin biosynthetic gene cluster of Yersinia enterocolitica: organization and siderophore-dependent regulation. J Bacteriol (1998) 2.18
Differentiation in virulence patterns of Escherichia coli possessing eae genes. Med Microbiol Immunol (1994) 2.16
The pesticin receptor of Yersinia enterocolitica: a novel virulence factor with dual function. Mol Microbiol (1994) 2.15
Invasion and intracellular development of the human granulocytic ehrlichiosis agent in tick cell culture. J Clin Microbiol (1999) 2.14
Development of rRNA-targeted PCR and in situ hybridization with fluorescently labelled oligonucleotides for detection of Yersinia species. J Clin Microbiol (1998) 2.13
Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome. J Med Microbiol (1994) 2.08
Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal diseases. J Clin Microbiol (1995) 2.04
[HYGEA (Hygiene in gastroenterology--endoscope reprocessing): Study on quality of reprocessing flexible endoscopes in hospitals and in the practice setting]. Z Gastroenterol (2002) 1.93
Virulence of Yersinia enterocolitica is closely associated with siderophore production, expression of an iron-repressible outer membrane polypeptide of 65,000 Da and pesticin sensitivity. Mol Microbiol (1993) 1.93
The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol (1993) 1.92
Substitution of two histidine residues in YadA protein of Yersinia enterocolitica abrogates collagen binding, cell adherence and mouse virulence. Mol Microbiol (1995) 1.91
Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients. J Clin Microbiol (2000) 1.91
Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol (2003) 1.86
Detection of Campylobacter pyloridis in patients with antrum gastritis and peptic ulcers by culture, complement fixation test, and immunoblot. J Clin Microbiol (1986) 1.85
Interaction of Yersinia enterocolitica with macrophages leads to macrophage cell death through apoptosis. Infect Immun (1997) 1.85
Persistence of Yersinia enterocolitica in man. Infection (1988) 1.83
Phage-associated cytotoxin production by and enteroadhesiveness of enteropathogenic Escherichia coli isolated from infants with diarrhea in West Germany. J Infect Dis (1987) 1.79
High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. J Pediatr (1991) 1.78
Cloning and characterization of a bradyzoite-specifically expressed gene (hsp30/bag1) of Toxoplasma gondii, related to genes encoding small heat-shock proteins of plants. Mol Microbiol (1995) 1.75
IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol (1998) 1.73
In vivo neutralization of tumor necrosis factor-alpha and interferon-gamma abrogates resistance to Yersinia enterocolitica infection in mice. Med Microbiol Immunol (1992) 1.73
Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages. Infect Immun (1993) 1.72
Differential contribution of Yersinia enterocolitica virulence factors to evasion of microbicidal action of neutrophils. Infect Immun (1996) 1.69
Prevalence of attaching and effacing Escherichia coli in stool samples from patients and controls. Zentralbl Bakteriol (1994) 1.69
Abiotrophia elegans sp. nov., a possible pathogen in patients with culture-negative endocarditis. J Clin Microbiol (1998) 1.68
Plasmid-encoded outer membrane protein YadA mediates specific binding of enteropathogenic yersiniae to various types of collagen. Infect Immun (1992) 1.68
T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica. Infect Immun (1992) 1.66
High-pathogenicity island of Yersinia pestis in enterobacteriaceae isolated from blood cultures and urine samples: prevalence and functional expression. J Infect Dis (2000) 1.66
Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut (2000) 1.62
Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3. Infect Immun (1992) 1.61
Experimental Yersinia enterocolitica infection in euthymic and T-cell-deficient athymic nude C57BL/6 mice: comparison of time course, histomorphology, and immune response. Infect Immun (1993) 1.60
Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR. J Clin Microbiol (1999) 1.58
Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis. Lab Invest (1994) 1.58
Experimental Yersinia infection of human synovial cells: persistence of live bacteria and generation of bacterial antigen deposits including "ghosts," nucleic acid-free bacterial rods. Infect Immun (1996) 1.57
Cloning and sequencing of a Shiga-like toxin II-related gene from Escherichia coli O157:H7 strain 7279. Zentralbl Bakteriol (1992) 1.56
Early gamma interferon mRNA expression is associated with resistance of mice against Yersinia enterocolitica. Infect Immun (1994) 1.53
The cytotoxin YopT of Yersinia enterocolitica induces modification and cellular redistribution of the small GTP-binding protein RhoA. J Biol Chem (1999) 1.52
Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae. J Clin Microbiol (1998) 1.52
Transverse myelitis associated with Mycoplasma pneumoniae infection. Clin Infect Dis (1998) 1.50
HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice. Hum Immunol (1995) 1.49
Nucleotide sequence and structural organization of Yersinia pestis insertion sequence IS100. FEMS Microbiol Lett (1994) 1.49
Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen. Infect Immun (1997) 1.46
Identification of a virulence-associated antigen of Toxoplasma gondii by use of a mouse monoclonal antibody. Infect Immun (1991) 1.45
Comparison of MB/BacT and BACTEC 460 TB systems for recovery of mycobacteria in a routine diagnostic laboratory. J Clin Microbiol (1999) 1.43
Outer membrane protein YadA of enteropathogenic yersiniae mediates specific binding to cellular but not plasma fibronectin. Infect Immun (1993) 1.41
Yersinia outer protein P of Yersinia enterocolitica simultaneously blocks the nuclear factor-kappa B pathway and exploits lipopolysaccharide signaling to trigger apoptosis in macrophages. J Immunol (2001) 1.41
Conservative management of biliary obstruction due to Fasciola hepatica. Clin Infect Dis (2000) 1.40
Comparison of fluorescent in situ hybridization and conventional culturing for detection of Helicobacter pylori in gastric biopsy specimens. J Clin Microbiol (2001) 1.37
Common and specific characteristics of the high-pathogenicity island of Yersinia enterocolitica. Infect Immun (1999) 1.36
Phenotypical and genotypical characterization of epidemic clumping factor-negative, oxacillin-resistant Staphylococcus aureus. J Clin Microbiol (1993) 1.36
Immunohistological characterization of the cellular immune response against Yersinia enterocolitica in mice: evidence for the involvement of T lymphocytes. Immunobiology (1993) 1.33
Evidence for two evolutionary lineages of highly pathogenic Yersinia species. J Bacteriol (1995) 1.32
Deletion of amino acids 29 to 81 in adhesion protein YadA of Yersinia enterocolitica serotype O:8 results in selective abrogation of adherence to neutrophils. Infect Immun (1996) 1.30
Yersinia enterocolitica in the synovial membrane of patients with Yersinia-induced arthritis. Arthritis Rheum (1990) 1.28
Heterogeneity among Whipple's-disease-associated bacteria. Lancet (1994) 1.28
Evaluation of BACTEC MGIT 960 and BACTEC 460TB systems for recovery of mycobacteria from clinical specimens of a university hospital with low incidence of tuberculosis. J Clin Microbiol (2001) 1.27
Functional analysis of yersiniabactin transport genes of Yersinia enterocolitica. Microbiology (2001) 1.25
Yersinia in intestinal biopsy specimens from patients with seronegative spondyloarthropathy: correlation with specific serum IgA antibodies. J Infect Dis (1989) 1.25
The Yersinia Ser/Thr protein kinase YpkA/YopO directly interacts with the small GTPases RhoA and Rac-1. FEBS Lett (2000) 1.23
Improved sensitivity of the polymerase chain reaction for detection of Toxoplasma gondii in biological and human clinical specimens. Eur J Clin Microbiol Infect Dis (1992) 1.23
Purified verotoxins of Escherichia coli O157:H7 decrease prostacyclin synthesis by endothelial cells. Microb Pathog (1988) 1.22
Temperature-dependent expression of flagella in Legionella. J Gen Microbiol (1991) 1.22
YopE of Yersinia, a GAP for Rho GTPases, selectively modulates Rac-dependent actin structures in endothelial cells. Cell Microbiol (2001) 1.21